Early diagnosis of acute coronary syndrome
暂无分享,去创建一个
Dorin Comaniciu | Martin Möckel | Matthias G. Friedrich | Stefan Blankenberg | Giorgio Minotti | Filippo Crea | Evangelos Giannitsis | Stephan Achenbach | Nicholas L. Mills | Daniel Lindholm | Okan Ekinci | Frank A. Flachskampf | D. Comaniciu | S. Achenbach | S. Blankenberg | P. Collinson | F. Crea | F. Flachskampf | M. Hlatky | M. Friedrich | B. Lindahl | K. Fox | H. Katus | E. Giannitsis | M. Möckel | T. Omland | G. Ducrocq | D. Lindholm | A. Himmelmann | W. G. Stough | N. Mills | O. Ekinci | M. Brueckmann | A. Ziegler | K. Hebert | G. Minotti | Bertil Lindahl | Keith A. A. Fox | Paul Collinson | Wendy Gattis Stough | D. Lautsch | Mark Hlatky | Hugo Katus | André Ziegler | Martina Brueckmann | Wilfried Dinh | Grégory Ducrocq | Kathy A. Hebert | Anders Himmelmann | Dominik Lautsch | Torbjørn Omland | Véronique Semjonow | W. Dinh | V. Semjonow
[1] G. Burke,et al. The HEART Pathway Randomized Trial: Identifying Emergency Department Patients With Acute Chest Pain for Early Discharge , 2014, Circulation. Cardiovascular quality and outcomes.
[2] Eric Boerwinkle,et al. Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study , 2011, Circulation.
[3] J. Menke,et al. Diagnostic accuracy and utility of coronary CT angiography with consideration of unevaluable results: A systematic review and multivariate Bayesian random-effects meta-analysis with intention to diagnose , 2016, European Radiology.
[4] Maarten L. Simoons,et al. The third universal definition of myocardial infarction , 2013 .
[5] Michael E. Hall,et al. Adenosine Stress Cardiovascular Magnetic Resonance–Observation Unit Management of Patients at Intermediate Risk for Acute Coronary Syndrome: A Possible Strategy for Reducing Healthcare-Related Costs , 2012, Current Treatment Options in Cardiovascular Medicine.
[6] J. Hallas,et al. Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. , 2014, The American journal of medicine.
[7] F. Apple,et al. Supply/demand type 2 myocardial infarction: should we be paying more attention? , 2014, Journal of the American College of Cardiology.
[8] P. Collinson,et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. , 2012, Clinical chemistry.
[9] R. Body,et al. Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation. , 2017, Clinical chemistry.
[10] B. Lindahl,et al. Prognostic Importance of Sex-Specific Cardiac Troponin T 99(th) Percentiles in Suspected Acute Coronary Syndrome. , 2016, The American journal of medicine.
[11] H. Nathoe,et al. Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins: Randomized Multicenter Study. , 2016, Journal of the American College of Cardiology.
[12] R. Dreyer,et al. Systematic Review of Patients Presenting With Suspected Myocardial Infarction and Nonobstructive Coronary Arteries , 2015, Circulation.
[13] F. Bamberg,et al. Highly sensitive troponin and coronary computed tomography angiography in the evaluation of suspected acute coronary syndrome in the emergency department. , 2016, European heart journal.
[14] H. Katus,et al. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. , 2010, Clinical chemistry.
[15] C. Schindler,et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. , 2012, Archives of internal medicine.
[16] D. Newby,et al. Comparison of the Efficacy and Safety of Early Rule-Out Pathways for Acute Myocardial Infarction , 2017, Circulation.
[17] B. Lindahl,et al. Consequences of implementing a cardiac troponin assay with improved sensitivity at Swedish coronary care units: an analysis from the SWEDEHEART registry. , 2016, European heart journal.
[18] J. Schulz-Menger,et al. Delayed Enhancement and T2-Weighted Cardiovascular Magnetic Resonance Imaging Differentiate Acute From Chronic Myocardial Infarction , 2004, Circulation.
[19] D. Atar,et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. , 2016, European heart journal.
[20] W. Gibler,et al. Risk Scores for Patients with Chest Pain: Evaluation in the Emergency Department , 2011, Current cardiology reviews.
[21] Baris Gencer,et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2011 .
[22] J. Greenslade,et al. Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. , 2015, The American journal of medicine.
[23] A. Khera,et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.
[24] B. Pathik,et al. Troponin-positive chest pain with unobstructed coronary arteries: incremental diagnostic value of cardiovascular magnetic resonance imaging. , 2016, European heart journal cardiovascular Imaging.
[25] J. Smith,et al. Diagnostic Accuracy of High-Sensitivity Cardiac Troponin T at Presentation Combined With History and ECG for Ruling Out Major Adverse Cardiac Events. , 2016, Annals of emergency medicine.
[26] Ò. Miró,et al. Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay , 2015, Canadian Medical Association Journal.
[27] S. Blankenberg,et al. Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study , 2014, European heart journal.
[28] Fred S Apple,et al. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. , 2012, Clinical chemistry.
[29] Pierre Coste,et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score , 2014, BMJ Open.
[30] B. Lindahl,et al. Type 2 myocardial infarction in clinical practice , 2014, Heart.
[31] A. Jaffe,et al. In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association , 2014, European heart journal. Acute cardiovascular care.
[32] D. Atar,et al. ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .
[33] C. Ayers,et al. Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis. , 2015, Clinical chemistry.
[34] A. Hoes,et al. A prospective validation of the HEART score for chest pain patients at the emergency department. , 2013, International journal of cardiology.
[35] F. Apple,et al. High-sensitivity cardiac troponin assays and unstable angina , 2018, European heart journal. Acute cardiovascular care.
[36] J. Greenslade,et al. Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm. , 2016, JAMA cardiology.
[37] G. Hillis,et al. A cluster randomized trial of objective risk assessment versus standard care for acute coronary syndromes: Rationale and design of the Australian GRACE Risk score Intervention Study (AGRIS). , 2015, American Heart Journal.
[38] P. Doevendans,et al. Chest pain in the emergency room: a multicenter validation of the HEART Score. , 2010, Critical pathways in cardiology.
[39] E. Antman,et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.
[40] J. Alpert,et al. How to use high-sensitivity cardiac troponins in acute cardiac care. , 2013, European heart journal.
[41] P. Collinson,et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study , 2015, The Lancet.
[42] P. Collinson,et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study , 2015, BMJ : British Medical Journal.
[43] Matthias Gutberlet,et al. Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .
[44] A. Wu,et al. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. , 2011, Clinical chemistry.
[45] Marc P. Bonaca,et al. Real-world application of "delta" troponin: diagnostic and prognostic implications. , 2013, Journal of the American College of Cardiology.
[46] A. Jaffe,et al. High-sensitive troponin T measurements: what do we gain and what are the challenges? , 2012, European heart journal.
[47] K. Eagle,et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) , 2006, BMJ : British Medical Journal.
[48] A. Jaffe,et al. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. , 2015, Clinical biochemistry.
[49] Fred S Apple,et al. Analytical characteristics of high-sensitivity cardiac troponin assays. , 2012, Clinical chemistry.
[50] J. Kelder,et al. Chest pain in the emergency room: value of the HEART score , 2008, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.
[51] A. Jaffe,et al. Sensitive Troponin Assay and the Classification of Myocardial Infarction , 2015, The American journal of medicine.
[52] G. Schuler,et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. , 2011, JAMA.
[53] A. Jaffe,et al. Editor’s Choice-Rule-in of acute myocardial infarction: Focus on troponin , 2017, European heart journal. Acute cardiovascular care.
[54] J. Alpert,et al. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. , 2014, The American journal of medicine.
[55] R. Body,et al. Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T. , 2016, Annals of emergency medicine.
[56] H. Bueno,et al. The race for higher sensitivity troponins, but for what prize? , 2016, European heart journal.
[57] Anthony H. Aletras,et al. Detecting Acute Coronary Syndrome in the Emergency Department With Cardiac Magnetic Resonance Imaging , 2003, Circulation.
[58] A. Jaffe,et al. Rapid rule out of acute myocardial infarction: novel biomarker-based strategies , 2017, European heart journal. Acute cardiovascular care.
[59] F. Apple,et al. Present and Future of Cardiac Troponin in Clinical Practice: A Paradigm Shift to High-Sensitivity Assays. , 2016, The American journal of medicine.
[60] M. Petzold,et al. Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality. , 2013, Journal of the American College of Cardiology.
[61] J. Seidman,et al. Fulminant Myocarditis with Combination Immune Checkpoint Blockade. , 2016, The New England journal of medicine.